These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32655196)

  • 41. Neutrophils and Immunity: From Bactericidal Action to Being Conquered.
    Teng TS; Ji AL; Ji XY; Li YZ
    J Immunol Res; 2017; 2017():9671604. PubMed ID: 28299345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases.
    Zecconi A; Scali F
    Immunol Lett; 2013 Feb; 150(1-2):12-22. PubMed ID: 23376548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement System Part II: Role in Immunity.
    Merle NS; Noe R; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2015; 6():257. PubMed ID: 26074922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How
    Abreu AG; Barbosa AS
    Front Immunol; 2017; 8():452. PubMed ID: 28473832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasticity in early immune evasion strategies of a bacterial pathogen.
    Bernard Q; Smith AA; Yang X; Koci J; Foor SD; Cramer SD; Zhuang X; Dwyer JE; Lin YP; Mongodin EF; Marques A; Leong JM; Anguita J; Pal U
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3788-E3797. PubMed ID: 29610317
    [No Abstract]   [Full Text] [Related]  

  • 46. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement evasion by human pathogens.
    Lambris JD; Ricklin D; Geisbrecht BV
    Nat Rev Microbiol; 2008 Feb; 6(2):132-42. PubMed ID: 18197169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fungal strategies for overcoming host innate immune response.
    Chai LY; Netea MG; Vonk AG; Kullberg BJ
    Med Mycol; 2009 May; 47(3):227-36. PubMed ID: 18654922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The innate immune response against Brucella in humans.
    Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP
    Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute Infection of Viral Pathogens and Their Innate Immune Escape.
    Rai KR; Shrestha P; Yang B; Chen Y; Liu S; Maarouf M; Chen JL
    Front Microbiol; 2021; 12():672026. PubMed ID: 34239508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial Evasion of Host Antimicrobial Peptide Defenses.
    Cole JN; Nizet V
    Microbiol Spectr; 2016 Feb; 4(1):. PubMed ID: 26999396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics.
    Ruest MK; Dennis JJ
    Pathogens; 2022 Aug; 11(8):. PubMed ID: 36015050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune Evasion Strategies of Relapsing Fever Spirochetes.
    Röttgerding F; Kraiczy P
    Front Immunol; 2020; 11():1560. PubMed ID: 32793216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunity against the Obligate Intracellular Bacterial Pathogen Rickettsia australis Requires a Functional Complement System.
    Riley SP; Fish AI; Del Piero F; Martinez JJ
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.
    Würzner R
    Mol Immunol; 1999; 36(4-5):249-60. PubMed ID: 10403478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
    Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
    mBio; 2017 May; 8(3):. PubMed ID: 28465428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategic targets of essential host-pathogen interactions.
    Blasi F; Tarsia P; Aliberti S
    Respiration; 2005; 72(1):9-25. PubMed ID: 15753628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial complement evasion.
    Rooijakkers SH; van Strijp JA
    Mol Immunol; 2007 Jan; 44(1-3):23-32. PubMed ID: 16875737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins.
    Fraga TR; Courrol Ddos S; Castiblanco-Valencia MM; Hirata IY; Vasconcellos SA; Juliano L; Barbosa AS; Isaac L
    J Infect Dis; 2014 Mar; 209(6):876-86. PubMed ID: 24163418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement Evasion Strategies of Viruses: An Overview.
    Agrawal P; Nawadkar R; Ojha H; Kumar J; Sahu A
    Front Microbiol; 2017; 8():1117. PubMed ID: 28670306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.